Eszopiclone
Lunesta
Non-Benzodiazepine Hypnotic (Z-Drug)
NADAC/unit
$0.0845
No Shortage
Tier 1: 68.4%
PA Req: 34.0%
10 Manufacturers
30 ANDAs
vs. brand Lunesta: Generic saves up to 99% per unit
Active Shortages
2025-06-26 Discontinuation of the manufacture of the drug, Teva Pharmaceuticals USA, Inc.
2025-06-26 Discontinuation of the manufacture of the drug, Teva Pharmaceuticals USA, Inc.
2025-06-26 Discontinuation of the manufacture of the drug, Teva Pharmaceuticals USA, Inc.
Market Intelligence
2024-07-10 Class III Recall: Dr. Reddy's Laboratories, Inc.
Generic Manufacturers
AUROBINDO PHARMA LTDDR REDDYS LABORATORIES LTDGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT VLUPIN LTDMACLEODS PHARMACEUTICALS LTDMYLAN PHARMACEUTICALS INCORBION PHARMACEUTICALS PRIVATE LTDSUN PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS USA INCWAYLIS THERAPEUTICS LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.